| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $931.8M | $845.5M | $694.7M |
| YoY Revenue Growth % | +10.2% | +21.7% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $186.4M | $165.7M | $136.2M |
| Operating Margin % | 20.0% | 19.6% | 19.6% |
| Net Income (GAAP) | $145.0M | $115.0M | $80.0M |
| EBITDA (Normalized) | $205.1M | $186.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $227.0M | $260.1M | $211.2M |
| Capital Expenditures (CapEx) | $23.3M | $25.4M | — |
| Free Cash Flow (FCF) | $203.7M | $234.7M | $211.2M |
| FCF Margin % | 21.9% | 27.8% | 30.4% |
| Return on Invested Capital (ROIC %) | 10.8% | 11.6% | — |
| Cash & Short-Term Equivalents | $306.0M | $273.6M | — |
| Total Debt (Short + Long Term) | $1.05B | $925.1M | — |
| Total Stockholders' Equity | $621.6M | $472.5M | — |